REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmarise Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmarise Sdn. Bhd. Profile Updated: December 11, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English Download a sample report

Pharmarise Sdn. Bhd. is based in Malaysia, with the head office in Kuala Lumpur. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 21, 2014. The latest financial highlights indicate a net sales revenue drop of 1.12% in 2018. Its total assets grew by 17.18% over the same period. The net profit margin of Pharmarise Sdn. Bhd. increased by 0.28% in 2018.

Headquarters
B-10-7, 1 Widuri Impian Condominum, Jalan 1/125G, Kampung Baru Salak Selatan
Kuala Lumpur; Federal Territories; Postal Code: 57100

Contact Details: Purchase the Pharmarise Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Pharmarise Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Pharmarise Sdn. Bhd. report to view the information.
Incorporation Date:
August 21, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharmarise Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.12%
Total operating revenue
-1.12%
Net Profit (Loss) for the Period
16.01%
Total assets
17.18%
Total equity
24.29%
Net Profit Margin
0.28%
Return on Equity (ROE)
-1.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?